Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MASH clinical trials and drugs pipeline: An impending tsunami
Mazen Noureddin
Hepatology (2024)
Closed Access | Times Cited: 17

Showing 17 citing articles:

Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 20
Meta‐Analysis of Placebo‐Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials
Matheus Souza, Marcio J. M. Amaral, Luan C. V. Lima, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025), pp. 100164-100164
Open Access | Times Cited: 1
Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
Shihao Zheng, Chengyuan Xue, Size Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis
Rutao Lin, Qinmei Sun, Xin Xin, et al.
Metabolism (2024) Vol. 161, pp. 156043-156043
Closed Access | Times Cited: 5
Comparative Efficacy of Promising Targets in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease And Steatohepatitis: A Systematic Review and Network Meta-Analysis
Jie Li, Wenjing Ni, Xue Bai, et al.
(2025)
Closed Access
Mechanistic insights into curcumin’s role in modulating autophagy and redox imbalance in experimentally induced MASH
Eman Ali Elkordy, Soha S. Zakaria, Khalid Alhussaini, et al.
Journal of Taibah University for Science (2025) Vol. 19, Iss. 1
Open Access
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
K.F. Au, Ming‐Hua Zheng, Wei‐Jei Lee, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 818-830
Closed Access | Times Cited: 4
Therapeutic potential of stem cell‐derived somatic cells to treat metabolic dysfunction‐associated steatotic liver disease and diabetes
Eduardo Hideo Gilglioni, Mayank Bansal, Wadsen St‐Pierre‐Wijckmans, et al.
Obesity Reviews (2025)
Closed Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access
Impact of the Underutilization of Vibration-Controlled Transient Elastography in MASLD Patients Without Insurance Coverage
Christopher Ma, D.S. Goldberg
Digestive Diseases and Sciences (2025)
Open Access
Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 281-283
Open Access | Times Cited: 3
Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics
Forkan Ahamed, Natalie Eppler, Elizabeth Jones, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 455-478
Open Access | Times Cited: 1
Bariatric-Metabolic Surgery: A Promising Solution for Non-Alcoholic Steatohepatitis
Arun Kumar
Biology Engineering Medicine and Science Reports (2024) Vol. 10, Iss. 1, pp. 14-16
Open Access
Identifying Predictors of Acute and Non-acute Decompensation in a Cohort of MASLD Predominant Cirrhosis
Akash Roy, Awanish Tewari, Nikhil Sonthalia, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. e232-e234
Closed Access
Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva
Giovanni Musso, Alberto Mantovani, Filippo Mariano, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access
Page 1

Scroll to top